In addition, all markers of hyperandrogenemia (e.g., testosterone, DHEAS, and androstenedione) were substantially decreased in both groups following bariatric surgery, but still significantly higher in the HYPERfemale group. The gene discussed is SULT2A1; the disease is polycystic ovary syndrome.